CHEMISTRY TOOLSCHEM TOOLS
ElementsCompoundsToolsBiologyMedicineReference
⌘K
All CompoundsAmino AcidsBiochemicalsInorganic
Periodic Table/Compounds/CHEMBL4863350

Elements

  • Periodic Table
  • Trends
  • Compare
  • Nuclides

Compounds

  • All Compounds
  • Amino Acids
  • Biochemicals
  • Inorganic

Tools

  • All Tools
  • Molar Mass
  • Electron Config
  • Decay Simulator
  • Balancer
  • Stoichiometry
  • Gas Laws
  • Solutions
  • Equilibrium
  • Kinetics
  • Oxidation States
  • Acid-Base
  • Solubility
  • Electrochemistry
  • Thermodynamics
  • Reactions
  • Spectroscopy
  • Orbitals
  • Lewis Structure
  • VSEPR
  • Nomenclature
  • Unit Converter

Biology

  • Biological Roles
  • Amino Acids
  • Metabolic Pathways
  • Nucleotides
  • Metals in Biology

Medicine

  • Drug Index
  • Drug Mechanisms
  • Radiopharmaceuticals
  • Toxicology
  • Therapeutic Elements

Reference

  • Glossary
  • Constants
  • Polyatomic Ions
  • Activity Series
  • Solubility Rules
  • Lab Safety
© Melvin Olsson 2025–2026
Data: IAEA & PubChem

CHEMBL4863350

C₂₃H₃₂O₃·356.500 g/mol·CID 155773719

IUPAC: 3-butyl-7-(1-butylcyclohexyl)-5-hydroxychromen-2-one

Also known as: BDBM50578464

2D structure of CHEMBL4863350

Molecular Structure

Molecular Propertiesmass · H-bonds · stereo

Molecular Weight

356.500g/mol

Exact Mass

356.235145Da

Monoisotopic Mass

356.235145Da

XLogP

8.1

Polar Surface Area

46.5Ų

Complexity

504

Formal Charge

0

H-Bond Donors

1

H-Bond Acceptors

3

Rotatable Bonds

7

Heavy Atoms

26

Stereo Centers

0

Bond Stereo

0

Drug-Likeness (Lipinski's Rule of Five)

✓ 356.5 g/mol
MW ≤ 500
✗ 8.1
LogP ≤ 5
✓ 1
H-bond donors ≤ 5
✓ 3
H-bond acceptors ≤ 10

1 violation — may still have acceptable bioavailability

Chemical IdentifiersSMILES · InChI

InChI

InChI=1S/C23H32O3/c1-3-5-10-17-14-19-20(24)15-18(16-21(19)26-22(17)25)23(11-6-4-2)12-8-7-9-13-23/h14-16,24H,3-13H2,1-2H3

Isomers8 compounds with formula C₂₃H₃₂O₃

2D structure of [(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate

[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate

CID 13791 · 356.5 g/mol

2D structure of [(3S,8R,9S,10R,13S,14S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate

[(3S,8R,9S,10R,13S,14S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate

CID 92855 · 356.5 g/mol

2D structure of [(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-yl] acetate

[(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-yl] acetate

CID 198013 · 356.5 g/mol

2D structure of 4,5-dihydroxy-2-methyl-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzaldehyde

4,5-dihydroxy-2-methyl-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzaldehyde

CID 131752742 · 356.5 g/mol

2D structure of 2,4-dihydroxy-6-methyl-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzaldehyde

2,4-dihydroxy-6-methyl-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzaldehyde

CID 10405997 · 356.5 g/mol

2D structure of [(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-yl] acetate

[(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-yl] acetate

CID 14589394 · 356.5 g/mol

2D structure of 4,6-dihydroxy-2-methyl-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzaldehyde

4,6-dihydroxy-2-methyl-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzaldehyde

CID 5317379 · 356.5 g/mol

2D structure of [3-[[(1R,2S,4aS,8aS)-1,2,4a-trimethyl-5-methylidene-3,4,6,7,8,8a-hexahydro-2H-naphthalen-1-yl]methyl]-4-hydroxyphenyl] acetate

[3-[[(1R,2S,4aS,8aS)-1,2,4a-trimethyl-5-methylidene-3,4,6,7,8,8a-hexahydro-2H-naphthalen-1-yl]methyl]-4-hydroxyphenyl] acetate

CID 11268298 · 356.5 g/mol

External Resources

PubChem ↗Wikipedia ↗